Reonomy Alternatives for CRE Research Teams
Acren helps CRE buyers turn a buy box into a ranked property pipeline and opportunity memo. Use Reonomy when the job is closer to a buyer guide across alternatives, not a single replacement claim.
Use Acren for the first pass: what fits, why it surfaced, and what still needs review.
Acren helps buyers turn a buy box into a shorter list of properties and a memo for each lead. Use Reonomy when the job is closer to a buyer guide across alternatives, not a single replacement claim.
Use Acren for ranked property pipelines, source-backed opportunity memos, owner/entity context, confidence labels, open questions, and next steps.
Teams comparing Reonomy with owner research, data platform, comp, title data, and acquisition memo tools.
What data does Acren actually organize?
Acren currently indexes 57,239,017 commercial property records across 50 states and the District of Columbia. Field, company, permit, and relationship coverage varies by jurisdiction and is measured separately.
| Evidence family | What is retained | Coverage posture |
|---|---|---|
| Property and assessment | Parcel, address, use, size, value, tax, and building fields | Nationwide inventory; field presence varies |
| Transactions and debt | Sales, mortgages, liens, maturities, assignments, and satisfactions | History nationwide; document depth varies |
| Owner and entity | Recorded owner strings, registrations, people, events, and match tiers | Registry and relationship depth varies |
| Permits and condition | Permits, code cases, equipment, inspections, and environmental context | Jurisdiction-specific |
| Verification | Observation dates, official-source links, caveats, conflicts, and open questions | Attached where reviewed |
The team needs a ranked property pipeline of properties to review, with the source trail and owner/entity questions attached.
Reonomy remains relevant for broad owner/property prospecting.
Acren identifies and explains a lead, then the team moves into market data, listings, comps, leases, expenses, debt, capex, or underwriting.
- You need to show how you got to a finding, not just the finding.
- You're targeting specific markets where source depth beats breadth.
- Pure prospect-list generation at national scale.
Mandate to memo before the deeper diligence stack.
Buy box to ranked property pipeline to opportunity memo.
A buyer guide across alternatives, not a single replacement claim.
An illustrative opportunity memo, not a black box score.
The public-record pattern and buy box reason this property entered the queue.
Who appears connected, with relationship type and confidence label.
Recorder, assessor, tax, permit, parcel, and entity records retained where available.
What still needs manual review before a team spends more diligence time.
Comp review, lease research, expense review, debt review, capex review, underwriting, watchlist, or pass.
Research priority only. No disposition intent, valuation, NOI, rent, return, or buy or sell recommendation.
- You mainly need proprietary sales comps, lease comps, rent rolls, valuation, NOI, rent forecasts, or an underwriting model.
- You need a listed-property marketplace, title insurance, legal advice, consumer screening, or a generic property data API.
- You want a tool to infer disposition intent, investment returns, or whether a buyer should pursue a property.
Acren is the first screen layer for finding and explaining commercial real estate opportunities before a team spends time in listing tools, comp tools, lease research, expense review, legal review, and underwriting.
Reonomy remains relevant for broad owner/property prospecting.
Teams still use market data, listing tools, comp databases, lease research, rent roll review, operating-expense diligence, legal review, appraisals, title work, and underwriting judgment where those workflows fit the decision.
Feature comparison
Last verified: 2026-08-21. This comparison is directional and should be reviewed against each vendor's current public materials and contract terms before purchase decisions.
Acren helps teams decide which properties deserve deeper work in comp review, lease research, expense review, debt review, capex review, and underwriting. Those tools still matter.
| Workflow Capability | Acren AI Analyst | Reonomy |
|---|---|---|
| Category | AI Acquisition Analyst for CRE teams. | Alternative Guide For Owner And Prospecting Workflows |
| Best fit | A buyer needs to decide which properties deserve review and what questions should follow. | Teams comparing Reonomy with owner research, data platform, comp, title data, and acquisition memo tools. |
| Primary output | Ranked property pipeline and source-backed opportunity memo. | A buyer guide across alternatives, not a single replacement claim. |
| Source trail | Visible record path behind key claims, with confidence labels and open questions. | Depends on the vendor's current product scope, licensed data, and display rules. |
| Publishes methodology and sources? | Yes. Public scoring, entity-resolution, validation, and responsible-use methods; named evidence remains attached in the product. | See current vendor public materials. Product-level source display and methodology disclosure vary. |
| Pricing model | First 30 days free; ongoing access is quoted per approved market. | Custom/contact sales or current public plan pricing; verify with the vendor. |
| Next step | Routes each lead to comp review, lease research, expense review, debt review, capex review, underwriting, watchlist, or pass. | Supports the competitor's core workflow rather than Acren's opportunity memo workflow. |
| Boundary | Research priority only. No disposition intent, valuation, NOI, rent, return, or buy or sell recommendation. | Review current public materials, contract terms, data rights, and permissible-use limits. |
| Best alternative when | The team needs source-backed acquisition memos and owner/entity caveats. | The team needs broad owner/property prospecting. |
| Alternative categories | Opportunity memo and acquisition research workflow. | Owner database, comp database, data platform, title/property data, or marketplace depending on the vendor. |
| Buyer decision | Use Acren when the next question is which properties deserve review. | Use another tool when the job is contacts, comps, data infrastructure, or title/property records. |
| Best for | Reviewed acquisition + lending research | Self-serve prospecting |
| Evidence model | Per-field ledger | Not exposed |
| Coverage promotion | County-by-county after QA | National rollup |
Public materials checked.
Sources reviewed include Reonomy, Altus, CompStak, Cherre, and DataTree public product pages. Product scope can change, so buyers should review current vendor materials, contracts, data rights, and permissible-use terms before purchase decisions.
Research priority, not a transaction or investment claim.
Responsible boundary. Not for FCRA-regulated use. Acren organizes commercial-property and business-entity records and ranks research priority from recorded evidence. It does not predict intent, provide valuation or underwriting, or support consumer-eligibility decisions.
How does Acren fit with Reonomy?
Acren fits before the deeper diligence stack when a team needs to decide which properties deserve review and what source-backed context should be attached.
Teams comparing Reonomy with owner research, data platform, comp, title data, and acquisition memo tools.
When should Acren come first?
Use Acren when the question is which commercial properties deserve review and what source-backed context should be reviewed before deeper diligence.
What should happen after Acren surfaces an opportunity?
Route the opportunity to market review, comps, lease research, expense review, underwriting, watchlist, contact research, assignment, or pass based on the buyer's diligence process.
Responsible boundary. Not for FCRA-regulated use. Acren organizes commercial-property and business-entity records and ranks research priority from recorded evidence. It does not predict intent, provide valuation or underwriting, or support consumer-eligibility decisions.